Login / Signup

Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial.

David R W JayneBrad H RovinEduardo MyslerRichard A FurieFrederic A HoussiauTeodora TrasievaJacob KnagenhjelmErik SchwetjeWeifeng TangRaj TummalaCatharina Lindholm
Published in: Lupus science & medicine (2023)
NCT02547922.
Keyphrases
  • open label
  • placebo controlled
  • clinical trial
  • double blind
  • study protocol
  • randomized controlled trial